Infochange India

Public health

Mon25Jul2016

You are here: Home | Public health | Analysis

The larger implications of the Novartis Glivec judgment

By Sudip Chaudhuri

The Supreme Court judgment on the Novartis-Glivec case has gone beyond technical and legal issues and linked the question of patenting with net benefits to society. What the judgment says and what it implies has significance for patent regimes in developing countries

 

Read more...

The cost of drugs: beyond the Supreme Court order

By Sanjay Nagral

The Supreme Court decision denying Novartis a patent for the cancer drug imanitib has been hailed as a victory for the affordable medicines movement. But it won’t make much difference if doctors continue to prescribe expensive branded drugs, patients believe that only expensive drugs work, and the government does little to support the manufacture of affordable medicines

Read more...

The need to cut pharma super-profits

The draft National Pharmaceuticals Pricing Policy 2011 brings 348 essential drugs under price control, but what about non-essential drugs, which are the bulk of those sold and which can be priced several times higher than their manufacturing cost, asks S Srinivasan

Read more...

National Vaccine Policy: For industry, not people's health

By Jacob Puliyel

The new National Vaccine Policy Draft 2011openly favours industry. It provides for advance market commitments for new vaccines, whereby government guarantees a market for the vaccine before it is tested and even if it is not efficacious. Should our vaccine policy focus on the health of our children, or the viability of the vaccine industry?

Read more...

Testing grounds, killing fields

As drug companies flock to India to conduct drug trials on the cheap, they capitalise on a combination of money-hungry researchers, a vulnerable population and a lax regulatory system. This is fertile ground for ethical violations that threaten the health and rights of poor Indians.  Read Ankur Paliwal’s article in Down To Earth

Read more...

Ethics, equity and genocide

Binayak Sen comments on the WHO’s report on the social determinants of health, and illustrates how an inequitable system keeps large sections of Indians walking with famine by their side

Read more...

Certification, corruption, and cost: The fight for a vaccine production policy

India is a global exporter of vaccines but 50% of our children under one are not completely immunised. The government has ordered the reopening of vaccine-manufacturing PSUs, but a strategic plan on consistently meeting India's basic vaccine needs is still not clear. Venkat Srinivasan tells the story of India’s vaccine production programme, a story of politics, dishonesty and misguided priorities

Read more...

From 'right to health' to 'right to health insurance'?

The government’s move to scale up and subsidise community health insurance schemes while doing nothing to improve healthcare service delivery is a flawed strategy. It’s like getting PDS shops to distribute mango kernels and mahua seeds as drought relief instead of foodgrains since the poor survive on these anyway, says Oommen C Kurian

Read more...

Trial by fire

By Sandhya Srinivasan

In a country where 26% of participants are enrolling for clinical trials just so that they get free or quality healthcare, it is dangerous to allow contract research organisations easy access to patient databases and to offer medicos payment for recruiting patients in trials, says Sandhya Srinivasan

Read more...

India's amateur handling of the H1N1 pandemic

Our panicky leaders have adopted the very strategy that the WHO warned against in dealing with the H1N1 outbreak, says leading virologist Dr T Jacob John, pointing out in this exclusive article for Infochange how government should have handled the pandemic

Read more...

Panic pandemic

The media and the government health services have unwittingly collaborated to create and escalate public alarm over the H1N1 influenza outbreak in India. Sandhya Srinivasan points out what their response to this public health crisis should have been

Read more...

Pandemic flu: What we know, what we don't, and what we should be worried about

By Sandhya Srinivasan

The swine flu pandemic is relatively mild in India so far, but in India and elsewhere what governments must do to prevent the occurrence of such outbreaks is strengthen public health systems, regulate corporate livestock farming, and ensure access to essential drugs and vaccines

Read more...

'Malaria deaths occur where political power ends'

The recent changes in the Indian government’s drug policy for the treatment of the deadly falciparum malaria are illogical and harmful. Sandhya Srinivasan analyses the short-sighted response to this public health crisis

Read more...

Malaria, a growing concern in India cities

By Dr Siddharth Agarwal

India marked World Malaria Day (April 25) with over 1 million cases of the disease in 2008, half of them of the dangerous P falciparum strain. Since this is largely due to unplanned urban growth and the growing number of urban poor, urban planning that is done keeping community needs in mind would go a long way in checking the spread of malaria

Read more...

Are leprosy figures being reduced any which way?

By Sandhya Srinivasan

A startling new study that surveyed 700,000 people in Raigad and Mumbai suggests that the burden of leprosy could be three to nine times the official figures. Obviously, people are not being detected and treated in time. Are the misguided policies of the National Leprosy Elimination Programme leading to a public health failure?

Read more...

India still on top of the world polio map

By Ranjita Biswas

Despite launching the largest ever mass immunisation campaign against polio in February 2003, targeting 165 million children, the battle against polio has not been won. To understand the causes of the repeated occurrence, we need to understand the profile of the wild polio virus

Read more...

Will the law against organ sale remain a moral victory?

By Sandhya Srinivasan

When India passed the Transplantation of Human Organs Act banning trade in organs, those who had agitated for the law may have thought they had won the battle. Instead the kidney trade has only flourished. The public is being told that the only way to put a stop to the kidney trade by people such as Amit Kumar, who has been running a global trade in organs since 1994, is to regulate the market for human organs

Read more...

Missing the wood for the trees

By Ramesh Venkataraman

Following the NFHS survey, the HIV numbers game has begun again. The point is that regardless of the actual number of people infected in India, there can be no complacency or drop in political and societal commitment towards HIV intervention and the rights of positive people

Read more...

The importance of social medicine

By George Thomas

Binayak Sen, who was arrested in Chhattisgarh in May, is one of very few medical practitioners in India who see their role as not just saving individual lives but examining and highlighting the social context of disease. Is it just to arrest a doctor who is acting according to his conscience?

Read more...